Модуляция транскрипции клеточных генов препаратом иммуномакс: активация генов интерферонов и интерлейкинов

Шувалов Александр Ииколаевич, Соколова Татьяна Михайловна, Шаповал Ирина Михайловна et al. · Иммунология · 2014

The well-known medical drug “Immunomax” produced by Russian firm “ImmaPharma” from plant material was studied. According to the results “Immunomax” regulates activity of many cellular genes. In human fibroblasts this drug induced transcription of multifunctional factors NF-kB and p53, it increased conciderably expression levels of beta1 -interferon and interferon-stimulated gene (ISG 15) and stimulated immune cytokine genes such as IL1 b, IL4, IL6, IL8 and IL17A. The “housekeeping genes” (18S ribosomal RNA, GAPDH, actin-beta, B2M) were also activateded. For the first time we studied “Immunomax” action on gene expression of subtypes (1, 2, 5, 21) alpha-IFN and IFN-beta1, IFN-gamma, IFN-lambda in human blood cells from donors. Observational drug effects were different and depended on initial constitutive levels of alpha-IFN. “Immunomax” stimulated donors' IFN-genes with defective activity (absent or lower). Our results demonstrate wide biological and antiviral potential of this drug in human cells in connection with IFN-system, cytokine production and cellular metabolism.

Cited by 0 works.

Authors